Product Details
Celecoxib Capsules IP
Vercox Capsules meet Indian Pharmacopoeia (IP) standards for the management of pain and inflammation. Specifically, each capsule delivers Celecoxib IP at 100mg. As a result, it offers targeted anti-inflammatory relief with a comparatively lower risk of gastrointestinal side effects than traditional NSAIDs.
The capsules contain:
- Celecoxib IP (100mg) – A selective COX-2 inhibitor that blocks the cyclooxygenase-2 enzyme responsible for inflammatory prostaglandin production. Consequently, it reduces pain, inflammation, and swelling while largely sparing the COX-1 enzyme that protects the gastric lining.
Physicians prescribe Vercox for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain conditions. In addition, its COX-2 selectivity makes it a preferred option for patients requiring long-term anti-inflammatory therapy who are at risk of gastrointestinal complications from non-selective NSAIDs. Because of this profile, Vercox suits rheumatology, orthopaedic, and general practice settings managing chronic and acute inflammatory pain.
Key Features:
- Overall, this IP-compliant formulation guarantees pharmaceutical-grade purity
- Additionally, the selective COX-2 mechanism supports a favourable gastrointestinal safety profile
- Furthermore, each capsule delivers precise, validated dosage accuracy at 100mg
- Notably, rigorous quality testing backs every stage of manufacturing
- Beyond that, blister packaging protects capsule integrity against light and moisture
- Ultimately, a reliable supply chain suits bulk distribution to hospitals, clinics, and pharmacies